UNSPSC 51285802: Hexamidine

This classification denotes an antibiotic with the molecular formula C20H26N4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3483C2H13H, chemically known as 4,6(1h,5h)-pyrimidinedione, 5-ethyldihydro-5-phenyl- but more generally known as hexamidine, which bears US NIH Compound Identifier 4909. European Medicines Agency schedules Hexamidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08029MIG.

UNSPSC 51285802 Hexamidine, a Commodity code, does not map to recent state and local procurement activity. The two opportunities tagged under this code involve pharmaceutical products — Doxycycline Hyclate and Ciprofloxacin Hydrochloride tablets through an Illinois Department of Public Health piggyback contract, and Naloxone and drug deactivation systems through a Seminole County, Florida procurement — neither of which is hexamidine. State and local buyers appear to be using this code incorrectly or the code's nominal scope does not align with current sourcing patterns in the dataset.

The Illinois award to Chartwell Rx LLC was completed on August 28, 2026 for $2.9 million over the contract's full three-year term including renewals, while the Seminole County solicitation (IFB 60459723LAS) closed on July 26, 2023 for annual purchases of 1,900 units of Naloxone and 800 drug deactivation systems with quarterly deliveries required. Neither solicitation explicitly targets hexamidine procurement. Without current open hexamidine solicitations in the state and local space, the code presents no actionable pursuit opportunity at this time.